Latest News and Information


Review and explore the latest press releases about our company, products, and research
Image of light streams
2019
2018
2017

For media
inquiries email:

media@legendbiotech.com

For investor relations
inquiries email:

investor@legendbiotech.com

The safety and efficacy of the agents and/or uses under investigation have not been established. There is no guarantee that the agents will receive health authority approval or become commercially available in any country for the uses being investigated.

*LCAR-B38M identifies the investigational product being studied in China and Janssen Biotech, Inc.'s JNJ-68284528 (also referenced as JNJ-4528) identifies the investigational product being studied in the United States, both of which are representative of the same CAR-T cell therapy.

X

But we are just getting started!

You are about to leave LegendBiotech.com.
Are you sure you want to leave so soon?

I AM SURE
KEEP ME HERE

By continuing to use our site, you agree to terms on our Legal Notice.
You can learn more about how we use cookies by viewing our Legal Notice.

CLOSE